{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001595097","name":"Corbus Pharmaceuticals Holdings, Inc.","summary":"Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on oncology and obesity therapeutics. Its pipeline includes CRB-701, a next-generation Nectin-4-targeting antibody drug conjugate (ADC) delivering MMAE payload for solid tumors, and CRB-913, a peripherally restricted CB1 receptor inverse agonist for obesity treatment. The company licenses CRB-701 from CSPC and conducts Phase 1/2 clinical trials in the U.S. and Europe.","people":[],"products":[{"name":"CRB-701","type":"platform","description":"Next-generation site-specific Nectin-4 targeting antibody drug conjugate (ADC) delivering MMAE cytotoxic payload for treatment of advanced solid tumors including HNSCC, cervical cancer, and metastatic urothelial cancer."},{"name":"CRB-913","type":"platform","description":"Highly peripherally restricted oral CB1 receptor inverse agonist small molecule for treatment of obesity, designed to minimize CNS and GI adverse events."},{"name":"CRB-601","type":"platform","description":"Anti-alphav8 integrin monoclonal antibody targeting TGF-beta activation in tumor microenvironment for solid tumors; program deprioritized with no plans for further enrollment."}],"partnerships":[{"partner_name":"CSPC Megalith Biopharmaceutical Co. Ltd.","partnership_type":"licensing","description":"Exclusive license obtained February 2023 to develop and commercialize CRB-701 in the U.S., Canada, EU, UK, and Australia for all oncology indications.","start_date":null},{"partner_name":"Merck (Keytruda/pembrolizumab)","partnership_type":"development","description":"CRB-701 being investigated in combination with Keytruda (pembrolizumab) in a PD-1 combination arm initiated June 2025 in the Phase 1/2 Western study.","start_date":null}],"affiliations":[],"origin":{"leaf":"816f35aa50951f3063bc7909749b5e23d7f6799c1d936c70ceec66c82a1da656","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"dce1427eb328d01605546045229a595a9a88d7a94f949d3e434646bb95280f31","parent":"5f98636893e96ba5a70aee23a9fe25e132f221e14392cab22d5cffb711d70884","source":"0001193125-26-098530","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}